5-methyltetrahydrofolic acid stimulates endothelin-1 production in low density lipoprotein-treated human endothelial cells.
OBJECTIVE
Several studies have shown the beneficial effects of folate treatment in improving cardiovascular function. However, the mechanisms involved have not been clearly identified. The aim of this study is to determine the effect of folates and vitamin B12 on endothelial vasoconstriction/vasodilatation parameters in cultured human endothelial cells incubated with human low density lipoproteins (LDL).


RESULTS
Human umbilical vein endothelial cells (HUVEC) were extracted from recently delivered umbilical cords, cultured until confluence was achieved, and then incubated for 24h with folic acid (FA), 5-methyltetrahydrofolic acid (5-MTHF) or vitamin B12 (B12) in the presence or absence of LDL that was isolated from healthy volunteers. Total nitrites (as a measure of nitric oxide production), thiobarbituric acid reactive species (TBARS, a parameter of lipid peroxidation), and endothelin-1 (ET-1) were determined in the incubation media. None of the vitamins, either in the presence or absence of LDL, was able to modify nitric oxide production by HUVEC. A significant reduction of ET-1 production was observed in LDL-treated cells. This effect was not modified by FA or B12; however, 5-MTHF caused a concentration-dependent increase on ET-1 production, an effect coincidental with reduced TBARS production.


CONCLUSIONS
This study demonstrates for the first time that 5-MTHF, but not FA or B12, increases ET-1 production in LDL-treated endothelial cells. Although this effect was associated with the antioxidant properties of this folate, our results show that additional specific mechanisms involving 5-MTHF-LDL interactions may be operating to regulate endothelial function.
Ronco
Ana Maria
AM
Laboratorio de Hormonas y Receptores, Instituto de Nutrición y Tecnología de los Alimentos, INTA, Universidad de Chile, Casilla 138-11, Santiago, Chile. amronco@inta.cl
Llanos
Miguel
M
Tamayo
Daniela
D
Hirsch
Sandra
S
D002478:Cells, Cultured; D003300:Copper / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000187:drug effects* / Q000378:metabolism; D019332:Endothelin-1 / Q000096:biosynthesis* / Q000235:genetics; D005492:Folic Acid / Q000494:pharmacology; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000378:metabolism / Q000494:pharmacology*; D009569:Nitric Oxide / Q000096:biosynthesis; D018384:Oxidative Stress; D047492:Peroxisome Proliferator-Activated Receptors / Q000502:physiology; D013763:Tetrahydrofolates / Q000494:pharmacology*; D014805:Vitamin B 12 / Q000494:pharmacology
D019332:Endothelin-1; D008077:Lipoproteins, LDL; D047492:Peroxisome Proliferator-Activated Receptors; D013763:Tetrahydrofolates; D009569:Nitric Oxide; D003300:Copper; D005492:Folic Acid; D014805:Vitamin B 12; C005984:5-methyltetrahydrofolate